Zydus Lifesciences informs about receipt of demand order-in-original

20 Aug 2024 Evaluate
Zydus Lifesciences has informed that Zydus Healthcare, a wholly owned subsidiary (ZHL) has received a Demand Order-In-Original (O-I-O) for the financial year 2019-20 from Commercial Tax Officer, Ward-8, Chandigarh, on the issue pertaining to Input Tax Credit (ITC). The details as required under regulation 30 of Listing Regulations read with SEBI Circular are enclosed.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

914.65 13.35 (1.48%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1271.05
Cipla 1510.90
Zydus Lifesciences 914.65
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×